PICTET BANK & TRUST Ltd lessened its holdings in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 81.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,209 shares of the company’s stock after selling 9,446 shares during the quarter. Procter & Gamble accounts for approximately 0.4% of PICTET BANK & TRUST Ltd’s portfolio, making the stock its 27th largest position. PICTET BANK & TRUST Ltd’s holdings in Procter & Gamble were worth $317,000 at the end of the most recent quarter.
Several other institutional investors have also recently bought and sold shares of PG. Halbert Hargrove Global Advisors LLC acquired a new position in shares of Procter & Gamble during the third quarter valued at about $25,000. Saranac Partners Ltd acquired a new stake in shares of Procter & Gamble in the 3rd quarter worth about $30,000. Corundum Trust Company INC bought a new position in Procter & Gamble in the 3rd quarter valued at about $32,000. Caitlin John LLC acquired a new position in Procter & Gamble during the 3rd quarter valued at about $34,000. Finally, Marquette Asset Management LLC bought a new stake in Procter & Gamble during the 3rd quarter worth approximately $37,000. Institutional investors and hedge funds own 65.77% of the company’s stock.
Wall Street Analysts Forecast Growth
PG has been the subject of several analyst reports. Barclays set a $155.00 price objective on Procter & Gamble in a research note on Friday, January 16th. Wells Fargo & Company reiterated an “overweight” rating and set a $177.00 price target on shares of Procter & Gamble in a report on Tuesday, February 17th. Piper Sandler began coverage on Procter & Gamble in a research report on Wednesday, January 7th. They issued a “neutral” rating and a $150.00 price target for the company. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Procter & Gamble in a report on Friday, March 27th. Finally, JPMorgan Chase & Co. upgraded shares of Procter & Gamble from a “neutral” rating to an “overweight” rating and upped their target price for the stock from $157.00 to $165.00 in a research note on Friday, January 23rd. Twelve investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to MarketBeat.com, Procter & Gamble presently has an average rating of “Moderate Buy” and an average price target of $167.06.
Key Headlines Impacting Procter & Gamble
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: Investors are rotating into defensive, dividend-rich consumer staples as recession odds rise, which supports demand for PG stock as a low-beta hedge. As Recession Odds Climb, Defensive Sectors Continue to Outperform (PG)
- Positive Sentiment: New OLAY peptide research was presented at a dermatology conference and P&G plans to integrate proprietary peptide technologies into product formulas—an R&D catalyst that could support premium pricing and brand value over time. OLAY Peptide Research Puts New Spotlight On Procter And Gamble Valuation
- Positive Sentiment: Recent session saw PG outperform the market on a prior close, reflecting investor preference for staples amid broader weakness. This shows defensive demand can provide near-term support. Procter & Gamble (PG) Ascends While Market Falls
- Neutral Sentiment: Analysts expect P&G’s upcoming fiscal Q3 results to show low single-digit EPS growth—this raises the bar modestly: a beat could lift the stock, while a slight miss may reinforce current caution. What to Expect From Procter & Gamble’s Next Quarterly Earnings Report
- Neutral Sentiment: Market commentary and analyst notes on consumer goods (including P&G and peers) are circulating, offering mixed takes that could influence near-term analyst revisions but contain no single decisive catalyst. Analysts Offer Insights on Consumer Goods Companies: Procter & Gamble (PG) and Costco (COST)
- Negative Sentiment: TD Cowen cut its price target to $142 from $156 and kept a Hold rating, citing oil-related input-cost inflation tied to geopolitical tensions—this analyst action puts downward pressure on sentiment and could limit near-term upside. TD Cowen Adjusts Price Target on Procter & Gamble to $142 from $156; Maintains Hold Rating
- Negative Sentiment: Reports say Deutsche Bank has lowered expectations for P&G, and coverage notes broadly point to cost pressures (including oil-related input inflation from Middle East tensions) that could compress margins if raw-material costs accelerate. Deutsche Bank Aktiengesellschaft Has Lowered Expectations for Procter & Gamble (NYSE:PG) Stock Price
- Negative Sentiment: Coverage summarizing analyst downgrades highlights Iran-war related cost risks and has contributed to recent negative headlines and downgrades that weigh on sentiment. Wall Street Downgrades Procter & Gamble Amid Iran War Cost Pressures and More
Procter & Gamble Stock Performance
Shares of Procter & Gamble stock opened at $144.19 on Thursday. The business’s fifty day simple moving average is $153.85 and its 200 day simple moving average is $149.84. The company has a current ratio of 0.72, a quick ratio of 0.51 and a debt-to-equity ratio of 0.49. Procter & Gamble Company has a 12 month low of $137.62 and a 12 month high of $174.80. The firm has a market capitalization of $335.10 billion, a P/E ratio of 21.36, a price-to-earnings-growth ratio of 5.08 and a beta of 0.41.
Procter & Gamble (NYSE:PG – Get Free Report) last announced its quarterly earnings data on Friday, January 23rd. The company reported $1.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.86 by $0.02. Procter & Gamble had a return on equity of 32.21% and a net margin of 19.30%.The firm had revenue of $22.21 billion during the quarter, compared to the consensus estimate of $22.36 billion. During the same quarter in the prior year, the company earned $1.88 EPS. The business’s revenue for the quarter was up 1.5% on a year-over-year basis. As a group, analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current year.
Procter & Gamble Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Tuesday, February 17th. Investors of record on Friday, January 23rd were given a dividend of $1.0568 per share. The ex-dividend date was Friday, January 23rd. This represents a $4.23 annualized dividend and a yield of 2.9%. Procter & Gamble’s dividend payout ratio is presently 62.67%.
Insider Buying and Selling at Procter & Gamble
In other Procter & Gamble news, CEO Ma. Fatima Francisco sold 5,549 shares of Procter & Gamble stock in a transaction dated Friday, February 27th. The shares were sold at an average price of $165.29, for a total value of $917,194.21. Following the sale, the chief executive officer owned 1,029 shares of the company’s stock, valued at approximately $170,083.41. The trade was a 84.36% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Moses Victor Javier Aguilar sold 15,169 shares of the stock in a transaction that occurred on Friday, February 13th. The shares were sold at an average price of $162.28, for a total transaction of $2,461,625.32. Following the transaction, the insider directly owned 44,735 shares of the company’s stock, valued at $7,259,595.80. This represents a 25.32% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 348,618 shares of company stock valued at $55,462,643 in the last three months. 0.20% of the stock is owned by corporate insiders.
Procter & Gamble Profile
Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
See Also
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
